Sign in

You're signed outSign in or to get full access.

Robert Daigle

Robert Daigle

President and Chief Executive Officer at AMTECH SYSTEMSAMTECH SYSTEMS
CEO
Executive
Board

About Robert C. Daigle

Robert C. Daigle (61) is President, Chief Executive Officer, and Chairman of the Board of Amtech Systems (ASYS). He joined the Board on August 12, 2021, became Chairman on May 11, 2022, and was appointed CEO on August 8, 2023. He holds a B.S. in Chemical and Materials Engineering from the University of Connecticut and an MBA from Rensselaer Polytechnic Institute, and previously served ~30 years at Rogers Corporation, including as Chief Technology Officer from 2013–2022 . Under Daigle’s tenure, company TSR declined from $74.37 to $50.74 (value of $100 investment) from FY 2022 to FY 2024, while net income moved from $17.4 million to a loss of $8.5 million over the same period . Revenues fell from $106.3 million (FY 2022) to $101.2 million (FY 2024) ; EBITDA moved from $6.6 million to $2.1 million over the same period (FY 2022–FY 2024) [Values retrieved from S&P Global].

Past Roles

OrganizationRoleYearsStrategic Impact
Rogers CorporationChief Technology Officer2013–2022Led engineered materials across EV/HEV, mobile, renewable, wireless infrastructure, and industrial markets
Rogers CorporationVarious senior executive roles~1992–2013Multiple leadership roles during 30-year tenure at a public advanced materials leader

External Roles

OrganizationRoleYearsStrategic Impact
No current external public company boards disclosed

Fixed Compensation

MetricFY 2023FY 2024
Base Salary ($)50,192 450,000
Bonus ($)
All Other Compensation ($)458 15,339
Total ($)1,263,454 1,411,299

Notes:

  • FY 2024 “All Other” includes $11,839 401(k) match plus HSA and lifestyle spending contributions .

Performance Compensation

Annual Incentive

ComponentMetricWeightingTargetActualPayoutVesting
2024 Annual BonusCompany operational goals (executive bonus program)N/AN/ANot earned for FY 2024; CEO forewent participation as of Feb 29, 2024$0N/A

Equity Incentives (Awards and Vesting)

Grant DateTypeSharesStrikeTermVesting ScheduleNotes
Aug 14, 2023Stock Options150,000$9.00 ~10 yrs (expires 8/14/2033) 50,000 vested immediately; remaining vest in equal installments on 1st and 2nd anniversaries Under 2022 Equity Plan
Feb 29, 2024Stock Options400,000$6.005 yrs (expires 3/1/2029) Equal installments on first, second, and third six-month anniversaries (Aug 8, 2024; Feb 8, 2025; Aug 8, 2025) Granted at ~25% premium to grant-date close; CEO forewent future bonus participation
Various (legacy)Stock Options6,000$9.99Expires 8/12/2031Legacy director grants
Various (legacy)Stock Options6,000$10.22Expires 3/2/2032Legacy director grants
FY 2024RSU Vesting (realized)63,410Vested in FY 2024; net shares 45,335 after tax withholdingValue realized $391,271

Plan safeguards:

  • No repricing of underwater options/SARs without shareholder approval .
  • Anti-hedging and anti-pledging policy prohibits hedging and pledging/margin accounts (adopted FY 2023) .

Equity Ownership & Alignment

ItemDetail
Total Beneficial Ownership527,705 shares; includes 378,668 options exercisable within 60 days of Jan 13, 2025; 3.6% ownership
Options (as of 9/30/2024)Exercisable: 6,000 @ $9.99; 6,000 @ $10.22; 100,001 @ $9.00; 133,334 @ $6.00. Unexercisable: 49,999 @ $9.00; 266,666 @ $6.00
Shares PledgedCompany policy prohibits pledging and margin accounts
HedgingProhibited (zero-cost collars, forwards, swaps, etc.)
RSUs Vested FY 202463,410 shares vested; gross value $391,271; net shares 45,335 after tax withholding
Stock Ownership GuidelinesCompany policies include ownership guidelines and potential forfeiture/recovery; specific multiples not disclosed

Upcoming vesting-related events (potential supply/flow considerations):

  • 400,000 option tranches vest on Feb 8, 2025 and Aug 8, 2025 .

Employment Terms

Term/ProvisionDetails
AgreementOriginal Employment Agreement dated Aug 14, 2023; Amendments No. 1 (Feb 29, 2024) and No. 2 (Aug 6, 2024)
Initial Term3 years
Base Salary$450,000 annually
Annual BonusEligible under original agreement; CEO forewent participation under Amendment No. 1
Equity Awards150,000 options at $9.00 (Aug 2023) with immediate 50,000 vest + remaining over 2 years; RSU grants originally contemplated were cancelled and replaced with 400,000 options at $6.00 (Feb 2024) with five-year term and accelerated six-month vesting cadence
Post-Termination Option ExerciseAmendment No. 2 permits exercise of vested options for the remaining term after termination (subject to exceptions)
Change-of-ControlEmployment agreement provides single-trigger full acceleration of unvested equity immediately prior to and contingent on CoC closing ; the Amended 2022 Plan generally provides double-trigger acceleration for participants (unless awards are not continued/assumed or award agreement provides otherwise)
Severance (Termination without Good Cause)Continued base salary at then-current rate; payment of any prior-year earned but unpaid bonus (timing aligned to other executives)
Good Cause DefinitionIncludes material breach, intentional nonperformance, dishonesty/fraud, felony involving moral turpitude, confirmed positive illegal drug test while performing services, material sanction by applicable professional body
Non-Compete12 months post-termination
Non-Solicit (Employees/Consultants/Contractors; Customers)24 months post-termination for both employees/consultants/contractors and customers/prospects in Competitive Business

Board Governance (Director Service, Committees, Dual-Role Implications)

  • Daigle serves as combined CEO and Chairman; Corporate Governance Guidelines state best practice is role separation; the Board appointed Michael Garnreiter as Lead Independent Director following Daigle’s CEO appointment .
  • Committees are fully independent: Audit (Chair: Garnreiter; members: Averick, Ludwig), Compensation (Chair: Averick; members: Garnreiter, Ludwig), Nominating & Governance (Chair: Ludwig; members: Averick, Garnreiter) .
  • Board meeting attendance: 8 meetings in FY 2024; no director attended less than 75% of meetings .
  • Director compensation structure (context): Non-employee Chair retainer $75,000; non-employee member $40,000; Committee chairs receive $15,000 (Audit) and $7,500 (Comp/NomGov); annual RSUs to non-employee directors that vest in one year; employees receive no director compensation. Daigle, as an employee, received $0 as director .
  • Board size and nominations: 5 members; current independent directors are Averick, Garnreiter, and Ludwig; diversity matrix disclosed; committees updated in 2022 charters .

Performance & Track Record

MetricFY 2022FY 2023FY 2024
Revenues ($USD)106,298,000 113,315,000 101,214,000
EBITDA ($USD)6,550,000*-4,104,000*2,102,000*
Net Income (Loss) ($USD, thousands)17,367 (12,582) (8,486)
TSR ($100 initial value)74.37 66.67 50.74

*Values retrieved from S&P Global.

Qualitative milestones:

  • Strategy emphasis on operational and supply chain improvements announced upon CEO appointment (Aug 2023) .
  • Equity program redesigned to emphasize out-of-the-money options with shorter term and accelerated vesting cadence; no bonus participation by CEO (alignment with equity upside) .

Compensation Structure Analysis

  • Shift from RSUs to options: RSU grants in the original agreement were cancelled and replaced with a 400,000-share option at a premium strike and 5-year term, signaling higher performance leverage and reduced guaranteed pay; CEO forewent bonus eligibility in exchange .
  • Safeguards: No option/SAR repricing without shareholder approval; anti-hedging/pledging; plan limits on non-employee director awards .
  • Pay-versus-performance: Company disclosed CAP vs SCT totals; TSR and net income trends frame alignment over FY 2022–FY 2024 .

Risk Indicators & Red Flags

  • Single-trigger CoC acceleration in CEO employment agreement (full vesting at change-of-control) contrasts with plan-level double-trigger standard—a governance risk to watch in M&A scenarios .
  • Combined CEO/Chairman role—mitigated by Lead Independent Director designation .
  • Equity overhang and limited remaining shares under plan may constrain future grants; as of Jan 13, 2025, 865,147 shares subject to awards and 21,871 shares available (context for dilution/overhang) .

Compensation Peer Group and Say-on-Pay

  • Peer group composition, target percentile, and historical say-on-pay approval percentages not disclosed in the proxy sections provided; the company solicits advisory say-on-pay and states it will consider shareholder feedback in case of significant opposition .

Expertise & Qualifications

  • Technical and materials engineering credentials with extensive executive experience at Rogers (CTO and prior roles), aligning with ASYS’s semiconductor capital equipment and consumables focus areas .

Work History & Career Trajectory

OrganizationRoleTenureNotable
Amtech SystemsDirector (since Aug 2021); Chairman (since May 2022); CEO (since Aug 2023)2021–presentCombined Chair/CEO; policy mitigated via Lead Independent Director
Rogers CorporationCTO; prior senior roles~1992–2022Led multiple segments; advanced materials for EV/HEV and industrial applications

Equity Plan Participation (Context)

ParticipantShares subject to awards since inception of 2022 Plan
Robert C. Daigle619,410

Investment Implications

  • Alignment and leverage: CEO compensation is heavily option-based, including a 400,000-share grant at a $6.00 strike with a 5-year term and accelerated vesting; the grant was struck at ~25% premium to market at grant and remains out-of-the-money versus the $5.43 close on Jan 13, 2025, aligning realized value with stock appreciation . Upcoming vesting dates (Feb 8, 2025; Aug 8, 2025) may create event-driven trading signals around potential exercises/sales .
  • Governance watchpoints: Single-trigger CoC acceleration in the CEO’s agreement is shareholder-unfriendly relative to the plan’s double-trigger approach; the combined Chair/CEO role persists, though mitigated by a Lead Independent Director .
  • Ownership and policy discipline: Beneficial ownership of 3.6% with substantial near-term exercisability supports “skin-in-the-game,” while anti-hedging/pledging policies reduce misalignment risks .
  • Performance trajectory: FY 2024 saw revenue decline and continued net losses, though EBITDA improved vs FY 2023; investors should monitor operational execution given management’s stated focus on supply chain and operations and the absence of cash bonuses for the CEO, which concentrates incentives on equity value creation .